KALA BIO
KALA
22 hedge funds and large institutions have $12.1M invested in KALA BIO in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.57% less ownership
Funds ownership: 1.48% → 0.92% (-0.57%)
12% less funds holding
Funds holding: 25 → 22 (-3)
19% less capital invested
Capital invested by funds: $14.8M → $12.1M (-$2.76M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$135K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$115K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$95.3K |
| 4 |
Two Sigma Investments
New York
|
+$88.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$221K |
| 2 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
-$85.1K |
| 3 |
Millennium Management
New York
|
-$9.78K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.94K |
| 5 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
-$6K |
KALA Hedge Fund Activity: Q3 2024 in Review
22 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q3 2024, worth a combined $12.1M — down 19% from $14.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of KALA and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $135K. The largest seller was Virtu Financial, exiting entirely with an estimated $221K sold.
- 22 institutional investors held KALA BIO (KALA) as of Q3 2024, down from 25 in Q2 2024.
- Funds reported $12.1M of KALA BIO stock for Q3 2024, down 19% quarter-over-quarter.
- 3 funds opened new KALA BIO positions in Q3 2024 and 6 closed out, a net change of -3 holders.
- The largest KALA BIO buyer in Q3 2024 was Renaissance Technologies, an estimated $135K added.
- The largest KALA BIO seller in Q3 2024 was Virtu Financial, an estimated $221K sold.
Based on aggregated 13F filings for Q3 2024.